Retroperitoneal lymphadenectomy remains an integral component in the multidisciplinary management of testicular cancer. Through the evolution of the procedure, continued refinements have led to diagnostic and therapeutic benefits as well…
The role of lymph node dissection (LND) in the staging and treatment of renal cell carcinoma has long been a topic of debate. The controversy has focused on whether LND…
Within the last decade, there has been an increased focus on lymphadenectomy or lymph node dissection (LND) in patients with upper tract urothelial carcinoma (UTUC). Although the data with regards…
With the rapid and widespread adoption of minimally invasive procedures (laparoscopic and robotic) for the treatment of prostate and bladder cancers in the last decade, concerns have been raised regarding…
The history of urologic lymphadenectomy is rich and diverse. Our current understanding of its use and benefits is a product of the hard work of numerous physicians and scientists from…
Pelvic lymph node dissection (PLND) at the time of cystectomy remains the most accurate method of staging and can have a positive impact on cancer control, and there is general…
Pelvic lymph node dissection is the only reliable technique to detect low-volume lymph node involvement in prostate cancer. Extended lymph node dissections that include the internal iliac chain in addition…
The metabolic syndrome (MetS) has become one of the major public health challenges worldwide. Emerging data have now clearly demonstrated its impact on male sexual function. The MetS appears to…
The Men’s Health Initiative of British Columbia (MHIBC) was created as a large-scale umbrella initiative aimed at connecting the dots by identifying, coordinating, and consolidating the existing foci of excellence…
As men age, there is an increase in the frequency of pathologic diseases affecting the genitourinary tract. Most notable among these changes are the rising prevalence of lower urinary tract…
